7/15/2020 7:36:50 AM
OpGen Reports Q2 Preliminary Total Revenue Of About $1.2 Mln
7/13/2020 8:39:15 AM
Menarini Silicon Partners With OpGen To Broaden Distribution Of CELLSEARCH Platform In North America
4/14/2020 7:35:00 AM
OpGen Q1 Total Revenue,excl Curetis Revenue, $617K
3/10/2020 11:03:08 AM
Curetis Shareholders Approve Merger With OpGen
10/7/2019 7:59:03 AM
OpGen Presents Preliminary Acuitas AMR Gene Panel Data For Detecting Urinary Tract Infections
5/14/2019 7:36:00 AM
OpGen Completes Initial FDA 510(k) Submission For Acuitas AMR Gene Panel Test
2/25/2019 8:40:45 AM
OpGen Appoints Don Elsey To Board
2/5/2019 7:33:50 AM
OpGen Completes Clinical Trials For Its Initial FDA 510(k) Submission
12/4/2018 7:33:32 AM
OpGen Receives Regulatory Approval To Market Pathogen Identification Products In Colombia
10/31/2018 7:35:55 AM
OpGen Partners With QIAGEN To Advance Rapid Diagnostics For Antimicrobial Resistant Bacteria